Omega Healthcare Investors, Inc. (OHI) At $26.46 Forms Bottom; Olin Has 1.29 Sentiment

Omega Healthcare Investors, Inc. (NYSE:OHI) Logo

Olin Corp (OLN) investors sentiment increased to 1.29 in Q4 2017. It’s up 0.34, from 0.95 in 2017Q3. The ratio increased, as 153 investment managers opened new and increased stock positions, while 119 reduced and sold stakes in Olin Corp. The investment managers in our database now hold: 144.77 million shares, down from 147.38 million shares in 2017Q3. Also, the number of investment managers holding Olin Corp in top ten stock positions was flat from 3 to 3 for the same number . Sold All: 30 Reduced: 89 Increased: 97 New Position: 56.

Omega Healthcare Investors, Inc. (OHI) formed multiple bottom with $24.87 target or 6.00% below today’s $26.46 share price. Omega Healthcare Investors, Inc. (OHI) has $5.49B valuation. The stock decreased 0.53% or $0.14 during the last trading session, reaching $26.46. About 1.53 million shares traded. Omega Healthcare Investors, Inc. (NYSE:OHI) has declined 18.67% since May 4, 2017 and is downtrending. It has underperformed by 30.22% the S&P500.

Among 11 analysts covering Omega Healthcare Investors (NYSE:OHI), 3 have Buy rating, 2 Sell and 6 Hold. Therefore 27% are positive. Omega Healthcare Investors has $46 highest and $21.0 lowest target. $27.67’s average target is 4.57% above currents $26.46 stock price. Omega Healthcare Investors had 29 analyst reports since July 21, 2015 according to SRatingsIntel. The company was initiated on Thursday, August 25 by BTIG Research. Stifel Nicolaus maintained Omega Healthcare Investors, Inc. (NYSE:OHI) on Tuesday, November 3 with “Buy” rating. SunTrust maintained the stock with “Buy” rating in Thursday, August 4 report. The rating was maintained by SunTrust on Wednesday, February 14 with “Hold”. The firm earned “Buy” rating on Wednesday, December 20 by Cantor Fitzgerald. The rating was upgraded by Jefferies to “Buy” on Thursday, February 25. The rating was maintained by SunTrust with “Hold” on Monday, January 22. The stock has “Hold” rating by Jefferies on Monday, June 26. The stock of Omega Healthcare Investors, Inc. (NYSE:OHI) earned “Outperform” rating by JMP Securities on Thursday, February 11. The rating was upgraded by Wells Fargo to “Outperform” on Thursday, February 15.

Investors sentiment decreased to 0.83 in 2017 Q4. Its down 0.59, from 1.42 in 2017Q3. It dropped, as 57 investors sold Omega Healthcare Investors, Inc. shares while 116 reduced holdings. 38 funds opened positions while 105 raised stakes. 141.70 million shares or 6.90% more from 132.55 million shares in 2017Q3 were reported. First Interstate Financial Bank accumulated 55 shares or 0% of the stock. Prudential Fincl reported 769,590 shares. Amalgamated Bancshares holds 0.03% or 39,383 shares in its portfolio. Amer International Grp holds 0.04% of its portfolio in Omega Healthcare Investors, Inc. (NYSE:OHI) for 409,754 shares. 160 are held by Focused Wealth Mngmt. 31,976 are owned by Cetera Advisors Limited Liability Corporation. Oxbow Ltd Liability Corp owns 136,300 shares or 0.7% of their US portfolio. Keybank National Association Oh holds 0% or 19,964 shares in its portfolio. Cypress Cap Mgmt Ltd Limited Liability Company (Wy) accumulated 500 shares or 0.02% of the stock. 800 were reported by Gemmer Asset Management Ltd Liability Com. Robeco Institutional Asset Mngmt Bv has 55,599 shares for 0.01% of their portfolio. Oakbrook Invests Llc has 0.01% invested in Omega Healthcare Investors, Inc. (NYSE:OHI). State Of Alaska Department Of Revenue reported 117,141 shares stake. Hightower Advisors reported 255,599 shares stake. Obermeyer Wood Counsel Lllp accumulated 21,200 shares.

Olin Corporation manufactures and distributes chemical products in the United States and internationally. The company has market cap of $5.13 billion. It operates through three divisions: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. It has a 9.41 P/E ratio. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, trichloroethylene and vinylidene chloride, hydrochloric acid, hydrogen, bleach products, and potassium hydroxide.

Since January 1, 0001, it had 3 insider buys, and 2 insider sales for $61,635 activity.

Ratings analysis reveals 50% of Olin’s analysts are positive. Out of 2 Wall Street analysts rating Olin, 1 give it “Buy”, 1 “Sell” rating, while 0 recommend “Hold”. The lowest target is $29.33 while the high is $37.0. The stock’s average target of $33.17 is 8.08% above today’s ($30.69) share price. OLN was included in 3 notes of analysts from September 7, 2016. The stock of Olin Corporation (NYSE:OLN) earned “Underperform” rating by Longbow on Wednesday, September 7. Cowen & Co maintained it with “Outperform” rating and $37.0 target in Friday, February 10 report.

Olin Corporation (NYSE:OLN) Institutional Positions Chart